PharVision Advisers’s Norwegian Cruise Line NCLH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,016
Closed -$258K – 436
2024
Q4
$258K Buy
+10,016
New +$253K 0.22% 208

Other funds holding NCLH

PharVision Advisers's NCLH Position: Q1 2025 in Review

PharVision Advisers sold out of Norwegian Cruise Line (NCLH) in Q1 2025, closing a stake of 10,016 shares — an estimated $258K sold.

PharVision Advisers first reported a position in NCLH in Q4 2024 and held it in 1 quarter. The position peaked at $258K in Q4 2024. 644 funds tracked by Wall St. Rank hold NCLH as of Q1 2025.

  • PharVision Advisers reported no remaining Norwegian Cruise Line position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 10,016 Norwegian Cruise Line shares in Q1 2025, an estimated $258K.
  • PharVision Advisers first reported a position in Norwegian Cruise Line in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Norwegian Cruise Line position peaked at $258K in Q4 2024.
  • 644 funds tracked by Wall St. Rank held Norwegian Cruise Line as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.